Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__178_B1,15 | Lung | Primary cancer | 2,650 | Other | 29.1% | 0.33 | 0.98 |
| NSCLC_38242124__IMC__178_B1,16 | Lung | Primary cancer | 2,846 | Other | 27.0% | 0.88 | 0.31 |
| NSCLC_38242124__IMC__178_B1,17 | Lung | Primary cancer | 3,474 | Tumor/Malignant | 45.6% | 0.99 | 0.06 |
| NSCLC_38242124__IMC__178_B1,18 | Lung | Primary cancer | 3,888 | Tumor/Malignant | 42.7% | 0.95 | 0.18 |
| NSCLC_38242124__IMC__178_B1,3 | Lung | Primary cancer | 2,479 | Tumor/Malignant | 50.6% | 0.91 | 0.27 |
| NSCLC_38242124__IMC__178_B1,5 | Lung | Primary cancer | 959 | Tumor/Malignant | 79.6% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__178_B1,6 | Lung | Primary cancer | 3,262 | Immune | 27.6% | 0.83 | 0.41 |
| NSCLC_38242124__IMC__178_B1,7 | Lung | Primary cancer | 2,276 | Tumor/Malignant | 49.7% | 0.97 | 0.13 |
| NSCLC_38242124__IMC__178_B1,8 | Lung | Primary cancer | 3,443 | Tumor/Malignant | 83.2% | 1.00 | 0.01 |
| NSCLC_38242124__IMC__178_B1,9 | Lung | Primary cancer | 2,545 | Tumor/Malignant | 55.4% | 0.92 | 0.24 |
| NSCLC_38242124__IMC__178_B2,1 | Lung | Primary cancer | 1,359 | Tumor/Malignant | 86.0% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__178_B2,10 | Lung | Primary cancer | 2,860 | Tumor/Malignant | 29.4% | 0.94 | 0.29 |
| NSCLC_38242124__IMC__178_B2,11 | Lung | Primary cancer | 877 | Tumor/Malignant | 45.7% | 0.97 | 0.13 |
| NSCLC_38242124__IMC__178_B2,12 | Lung | Primary cancer | 1,971 | Immune | 27.5% | 0.32 | 0.99 |
| NSCLC_38242124__IMC__178_B2,13 | Lung | Primary cancer | 2,500 | Tumor/Malignant | 56.8% | 0.95 | 0.16 |
| NSCLC_38242124__IMC__178_B2,15 | Lung | Primary cancer | 5,479 | Immune | 57.3% | 0.95 | 0.14 |
| NSCLC_38242124__IMC__178_B2,16 | Lung | Primary cancer | 3,878 | Tumor/Malignant | 86.5% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__178_B2,17 | Lung | Primary cancer | 1,254 | Tumor/Malignant | 26.1% | 0.84 | 0.41 |
| NSCLC_38242124__IMC__178_B2,18 | Lung | Primary cancer | 2,314 | Tumor/Malignant | 47.6% | 1.00 | 0.04 |
| NSCLC_38242124__IMC__178_B2,2 | Lung | Primary cancer | 2,287 | Tumor/Malignant | 32.4% | 0.82 | 0.44 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__178_B1,15 | Lung | Primary cancer | 2,650 | Stromal | 25.7% | 0.77 | 0.54 |
| NSCLC_38242124__IMC__178_B1,16 | Lung | Primary cancer | 2,846 | Tumor/Malignant | 25.5% | 0.93 | 0.15 |
| NSCLC_38242124__IMC__178_B1,17 | Lung | Primary cancer | 3,474 | Tumor/Malignant | 47.5% | 0.99 | 0.07 |
| NSCLC_38242124__IMC__178_B1,18 | Lung | Primary cancer | 3,888 | Tumor/Malignant | 42.5% | 0.94 | 0.18 |
| NSCLC_38242124__IMC__178_B1,3 | Lung | Primary cancer | 2,479 | Tumor/Malignant | 33.5% | 0.70 | 0.59 |
| NSCLC_38242124__IMC__178_B1,5 | Lung | Primary cancer | 959 | Tumor/Malignant | 68.1% | 1.00 | 0.01 |
| NSCLC_38242124__IMC__178_B1,6 | Lung | Primary cancer | 3,262 | Lymphoid | 24.5% | 0.80 | 0.46 |
| NSCLC_38242124__IMC__178_B1,7 | Lung | Primary cancer | 2,276 | Tumor/Malignant | 48.0% | 0.98 | 0.11 |
| NSCLC_38242124__IMC__178_B1,8 | Lung | Primary cancer | 3,443 | Tumor/Malignant | 83.1% | 1.00 | 0.01 |
| NSCLC_38242124__IMC__178_B1,9 | Lung | Primary cancer | 2,545 | Tumor/Malignant | 42.3% | 0.96 | 0.17 |
| NSCLC_38242124__IMC__178_B2,1 | Lung | Primary cancer | 1,359 | Tumor/Malignant | 86.8% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__178_B2,10 | Lung | Primary cancer | 2,860 | Tumor/Malignant | 29.1% | 0.93 | 0.29 |
| NSCLC_38242124__IMC__178_B2,11 | Lung | Primary cancer | 877 | Tumor/Malignant | 44.1% | 0.98 | 0.10 |
| NSCLC_38242124__IMC__178_B2,12 | Lung | Primary cancer | 1,971 | Stromal | 19.2% | 0.33 | 1.10 |
| NSCLC_38242124__IMC__178_B2,13 | Lung | Primary cancer | 2,500 | Tumor/Malignant | 52.0% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__178_B2,15 | Lung | Primary cancer | 5,479 | Lymphoid | 55.5% | 0.95 | 0.14 |
| NSCLC_38242124__IMC__178_B2,16 | Lung | Primary cancer | 3,878 | Tumor/Malignant | 83.0% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__178_B2,17 | Lung | Primary cancer | 1,254 | Tumor/Malignant | 26.3% | 0.84 | 0.40 |
| NSCLC_38242124__IMC__178_B2,18 | Lung | Primary cancer | 2,314 | Tumor/Malignant | 48.8% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__178_B2,2 | Lung | Primary cancer | 2,287 | Tumor/Malignant | 29.4% | 0.85 | 0.40 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__178_B1,15 | Lung | Primary cancer | 2,650 | Fibroblast | 31.1% | 0.62 | 0.74 |
| NSCLC_38242124__IMC__178_B1,16 | Lung | Primary cancer | 2,846 | Tumor/Malignant cell | 27.0% | 0.92 | 0.18 |
| NSCLC_38242124__IMC__178_B1,17 | Lung | Primary cancer | 3,474 | Tumor/Malignant cell | 67.6% | 0.95 | 0.18 |
| NSCLC_38242124__IMC__178_B1,18 | Lung | Primary cancer | 3,888 | Tumor/Malignant cell | 42.7% | 0.95 | 0.18 |
| NSCLC_38242124__IMC__178_B1,3 | Lung | Primary cancer | 2,479 | Tumor/Malignant cell | 50.4% | 0.91 | 0.27 |
| NSCLC_38242124__IMC__178_B1,5 | Lung | Primary cancer | 959 | Tumor/Malignant cell | 68.1% | 1.00 | 0.01 |
| NSCLC_38242124__IMC__178_B1,6 | Lung | Primary cancer | 3,262 | B cell | 28.5% | 0.48 | 0.83 |
| NSCLC_38242124__IMC__178_B1,7 | Lung | Primary cancer | 2,276 | Tumor/Malignant cell | 51.4% | 0.96 | 0.15 |
| NSCLC_38242124__IMC__178_B1,8 | Lung | Primary cancer | 3,443 | Tumor/Malignant cell | 90.1% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__178_B1,9 | Lung | Primary cancer | 2,545 | Tumor/Malignant cell | 55.8% | 0.92 | 0.25 |
| NSCLC_38242124__IMC__178_B2,1 | Lung | Primary cancer | 1,359 | Tumor/Malignant cell | 86.6% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__178_B2,10 | Lung | Primary cancer | 2,860 | Tumor/Malignant cell | 37.9% | 0.91 | 0.40 |
| NSCLC_38242124__IMC__178_B2,11 | Lung | Primary cancer | 877 | Tumor/Malignant cell | 45.4% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__178_B2,12 | Lung | Primary cancer | 1,971 | Fibroblast | 23.3% | 0.58 | 0.87 |
| NSCLC_38242124__IMC__178_B2,13 | Lung | Primary cancer | 2,500 | Tumor/Malignant cell | 56.2% | 0.96 | 0.16 |
| NSCLC_38242124__IMC__178_B2,15 | Lung | Primary cancer | 5,479 | B cell | 35.8% | 0.91 | 0.26 |
| NSCLC_38242124__IMC__178_B2,16 | Lung | Primary cancer | 3,878 | Tumor/Malignant cell | 86.2% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__178_B2,17 | Lung | Primary cancer | 1,254 | Tumor/Malignant cell | 25.6% | 0.84 | 0.41 |
| NSCLC_38242124__IMC__178_B2,18 | Lung | Primary cancer | 2,314 | Tumor/Malignant cell | 67.8% | 0.95 | 0.16 |
| NSCLC_38242124__IMC__178_B2,2 | Lung | Primary cancer | 2,287 | Fibroblast | 32.7% | 0.81 | 0.51 |